Top Tweets for #trofuse005

about 17 hours ago

2 wks to #ESMO26! Here’s a📝of🔑studies for GeneralOnc that could change/reinforce SoC: - #INTerpath001 - #VOLGA - #ANZUP1801 - #LITESPARK011 - #DeLLphi305 - #SAFFRON - #CLARITYGastric01 - #MOIO - #TroFuse005 - Breast Ca Updates #OncTwitter @myESMO @OncoAlert

OncBrothers's tweet photo. 2 wks to #ESMO26! Here’s a📝of🔑studies for GeneralOnc that could change/reinforce SoC:

- #INTerpath001
- #VOLGA
- #ANZUP1801
- #LITESPARK011
- #DeLLphi305
- #SAFFRON
- #CLARITYGastric01
- #MOIO
- #TroFuse005
- Breast Ca Updates

#OncTwitter @myESMO @OncoAlert https://t.co/9uGw605Q0W

Mali Barbi, MD MSc | Breast & Gyn Oncologist

@DrBarbiOnc

10 days ago

Following #ESMO26 from afar this year, but following closely. Three questions I'm bringing to it in gyn onc: Endometrial: are we starting to treat it like breast cancer? #TroFuse005 (sac-TMT, TROP2 ADC, Presidential Symposium, Oct 26) after platinum and IO, OS and PFS met. Plus sac-TMT + pembro in post-platinum pMMR EC (phase 2). Molecular groups driving treatment, ADCs. We are slowly getting there. Ovarian: Here ADCs are everywhere, and still no answer for ADC after ADC. The PROC readout I'm watching is #DENALI (azenosertib, WEE1i, OS, Oct 23), with phase 3 ASPENOVA in cyclin E1+ disease behind it. Not an ADC. Maybe that's the most clinically relevant point. Cervical: did we find a better way to prevent it? My biggest agenda, and I haven't seen a prevention abstract on the program yet. We have the vaccine and screening. What we don't have is reach. Going to be a busy October. Follow along. #gyncsm

579

Top Tweets for #trofuse005

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users